The role of interleukin 13 and interleukin 5 in asthma;Rola interleukin 13 i 5 w astmie

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 146-155

  Tomasiak Łozowska, Maria Magdalena ^a   Bodzenta Łukaszyk, Anna ^a   Tomasiak, Marian ^b   Skiepko, Roman ^a   Ziȩtkowski, Ziemowit ^a  

^a Klinika Reumatologii i Chorob Wewnetrznych   (Poland)

^b NONE   (Poland)

Author keywords

Asthma; Interleukin 13; Interleukin 5

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 5;

ASTHMA; BRONCHUS HYPERREACTIVITY; EOSINOPHIL; HUMAN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ASTHMA; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5;

EID: 77954743519     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Akimoto T., Numata F., Tamura M., Takata Y., Higashida N., Takashi T., Takeda K., Akira S.: Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT) 6-deficient mice. J. Exp. Med., 1998;187:1537-1542 (Pubitemid 28215412)
2. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T.: Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem., 1990;59:783-836
3. Barry S. C., McKenzie A. N., Strath M., Sanderson C. J.: Analysis of interleukin 5 receptors on murine eosinophils: a comparison with receptors on B13 cells. Cytokine, 1991;3:339-344
4. Bates M. E., Green V. L., Bertics P. J.: ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C (4) biosynthesis. J. Biol. Chem., 2000;275:10968-10975 (Pubitemid 30212734)
5. Bazan J. F.: Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA, 1990;87:6934-6938
6. Berry M. A., Parker D., Neale N., Woodman L., Morgan A., Monk P., Bradding P., Wardlaw A. J., Pavord I. D., Brightling C. E.: Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol., 2004;114:1106-1109 (Pubitemid 39469151)
7. Blanchard C., Mishra A., Saito-Akei H., Monk P., Anderson I., Rothenberg M. E.: Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin. Exp. Allergy, 2005;35:1096-1103 (Pubitemid 41603145)
8. Blyth D. I., Wharton T. F., Pedrick M. S., Savage T. J., Sanjar S.: Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am. J. Respir. Cell Mol. Biol., 2000;23:241-246 (Pubitemid 30656435)
9. Bousquet J., Chanez P., Lacoste J. Y., Barnéon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P., Michel F. B.: Eosinophilic infammation in asthma. N. Engl. J. Med., 1990;323:1033-1039
10. Bree A., Schlerman F. J., Wadanoli M., Tchistiakova L., Marquette K., Tan X. Y., Jacobson B. A., Widom A., Cook T. A., Wood N., Vunnum S., Krykbaev R., Xu X., Donaldson D. D., Goldman S. J., Sypek J., Kasaian M. T.: IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J. Allergy Clin. Immunol., 2007;119:1251-1257 (Pubitemid 46654187)
11. Brown K. D., Zurawski S. M., Mosmann T. R., Zurawski G.: A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol., 1989;142:679-687 (Pubitemid 19039994)
12. Camoretti-Mercado B., Solway J.: Transforming growth factor-β1 and disorders of the lung. Cell Biochem. Biophys., 2005;43:131-148 (Pubitemid 41095280)
13. Caramori G., Groneberg D., Ito K., Casolari P., Adcock I. M., Papi A.: New drugs targeting Th2 lymphocytes in asthma. J. Occup. Med. Toxicol., 2008;3(Suppl. 1):S6
14. Chen Z. G., Li M., Chen Y. F., Ji J. Z., Li Y. T., Chen W., Chen F. H., Chen H.: Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children. Chin. Med. J., 2009;122:1157-1161
15. Chomarat P., Banchereau J.: Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol., 1998;17:1-52 (Pubitemid 29014544)
16. Coyle A. J., Ackerman S. J., Irvin C. G.: Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am. Rev. Respir. Dis., 1993;147:896-900 (Pubitemid 23093813)
17. Daines M. O., Hershey G. K.: A novel mechanism by which interferon-γ can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor a-2 and their rapid mobilization by interferon-γ. J. Biol. Chem., 2002;277:10387-10393 (Pubitemid 34968158)
18. Daniels S. E., Bhattacharrya S., James A., Leaves N. I., Young A., Hill M. R., Faux J. A., Ryan G. F., le Söuef P. N., Lathrop G. M., Musk A. W., Cookson W. O.: A genome-wide search for quantitative trait loci underlying asthma. Nature, 1996;383:247-250 (Pubitemid 26317671)
19. Denburg J. A.: Basophil and mast cell lineages in vitro and in vivo. Blood, 1992;79:846-860
20. Denburg J. A., Sehmi R., Upham J.: Regulation of IL-5 receptor on eosinophil progenitors in allergic inflammation: role of retinoic acid. Int. Arch. Allergy Immunol., 2001;124:246-248 (Pubitemid 32304817)
21. Denburg J. A., Silver J. E., Abrams J. S.: Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. Blood, 1991;77:1462-1468
22. Denburg J. A., Woolley M., Leber B., Linden M., O'Byrne P.: Basophil and eosinophil differentiation in allergic reactions. J. Allergy Clin. Immunol., 1994, 94:1135-1141
23. Doherty T. M., Kastelein R., Menon S., Andrade S., Coffman R. L.: Modulation of murine macrophage function by IL-13. J. Immunol., 1993;151:7151-7160 (Pubitemid 24001089)
24. Du Y. C., Xu J. Y., Zhang S. J.: Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V., and transforming growth factor p1 in the airway walls of sensitized rats. Chin. Med. J., 2004;117:908-912
25. Egan R. W., Umland S. P., Cuss F. M., Chapman R. W: Biology of interleukin-5 and its relevance to allergic disease. Allergy, 1996;51:71-81 (Pubitemid 26174833)
26. Endo T., Ogushi F., Sone S.: LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ. J. Immunol., 1996;156:2240-2246
27. Espinosa K., Bossé Y., Stankova J., Rola-Pleszczynski M.: CysLT1 receptor upregulation by TGF-β and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J. Allergy Clin. Immunol., 2003;111:1032-1040 (Pubitemid 36570864)
28. Eum S. Y., Maghni K., Hamid Q., Eidelman D. H., Campbell H., Isogai S., Martin J. G.: Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J. Allergy Clin. Immunol., 2003;111:1049-1061 (Pubitemid 36570866)
29. Fallon P. G., Emson C. L., Smith P., McKenzie A. N.: IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J. Immunol., 2001;166:2712-2716 (Pubitemid 32173512)
30. Fichtner-Feigl S., Strober W., Kawakami K., Puri R. K., Kitani A.: IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med., 2006;12:99-106 (Pubitemid 43050083)
31. Flood-Page P. T., Menzies-Gow A. N., Kay A. B., Robinson D. S.: Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med., 2003;167:199-204 (Pubitemid 36076080)
32. Flood-Page P., Menzies-Gow A., Phipps S., Ying S., Wangoo A., Ludwig M. S., Barnes N., Robinson D., Kay A. B.: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest., 2003;112:1029-1036 (Pubitemid 38056318)
33. Flood-Page P., Swenson C., Faiferman I., Matthews J., Williams M., Brannick L., Robinson D., Wenzel S., Busse W., Hansel T. T., Barnes N. C., International Mepolizumab Study Group: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am. J. Respir. Crit. Care Med., 2007;176:1062-1071 (Pubitemid 350223751)
34. Foster P. S., Hogan S. P., Ramsay A. J., Matthaei K. I., Young I. G.: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med., 1996;183:195-201 (Pubitemid 26028759)
35. Gauvreau G. M., Ellis A. K., Denburg J. A.: Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin. Exp. Allergy, 2009;39:1297-1306
36. Gleich G. J.: Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol., 2000;105:651-663 (Pubitemid 30226437)
37. Gounni A. S., Gregory B., Nutku E., Aris F., Latifa K., Minshall E., North J., Tavernier J., Levit R., Nicolaides N., Robinson D., Hamid Q.: Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood, 2000;96:2163-2171
38. Green R. H., Brightling C. E., Woltmann G., Parker D., Wardlaw A. J., Pavord I. D.: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax, 2002;57:875-879 (Pubitemid 35178612)
39. Greenfeder S., Umland S. P., Cuss F. M., Chapman R. W., Egan R. W.: Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir. Res., 2001;2:71-79 (Pubitemid 34187910)
40. Gregory B., Kirchem A., Phipps S., Gevaert P., Pridgeon C., Rankin S. M., Robinson D. S.: Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor a-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor a expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor a expression. J. Immunol., 2003;170:5359-5366 (Pubitemid 36617820)
41. Grünig G., Warnock M., Wakil A. E., Venkayya R., Brombacher F., Rennick D. M., Sheppard D., Mohrs M., Donaldson D. D., Locksley R. M., Corry D. B.: Requirement for IL-13 independently of IL-4 in experimental asthma. Science, 1998;282:2261-2263 (Pubitemid 29004075)
42. Haldar P., Brightling C. E., Hargadon B., Gupta S., Monteiro W., Sousa A., Marshall R. P., Bradding P., Green R. H., Wardlaw A. J., Pavord I. D.: Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med., 2009;360:973-984
43. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A. J., Corrigan C. J., Bradley B., Durham S. R., Collins J. V., Jeffery P. K., Quint D. J., Kay A. B.: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest., 1991;87:1541-1546
44. Hellman C., Halldén G., Hylander B., Lundahl J.: Regulation of the interleukin-5 receptor α-subunit on peripheral blood eosinophils from healthy subjects. Clin. Exp. Immunol., 2003;131:75-81 (Pubitemid 36098825)
45. Hershey G. K.: IL-13 receptors and signaling pathways: an evolving web. J. Allergy Clin. Immunol., 2003;111:677-690 (Pubitemid 36470232)
46. Hogan S. P., Matthaei K. I., Young J. M., Koskinen A., Young I. G., Foster P. S.: A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol., 1998;161:1501-1509 (Pubitemid 28380583)
47. Hogan S. P., Mould A., Kikutani H., Ramsay A. J., Foster P. S.: Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest., 1997;99:1329-1339 (Pubitemid 27142771)
48. Horie S., Okubo Y., Hossain M., Sato E., Nomura H., Koyama S., Suzuki J., Isobe M., Sekiguchi M.: Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern. Med., 1997;36:179-185 (Pubitemid 27249724)
49. Humbert M., Corrigan C. J., Kimmitt P., Till S. J., Kay A. B., Durham S. R.: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am. J. Respir. Crit. Care Med., 1997;156:704-708 (Pubitemid 27396404)
50. Ingley E., Young I. G.: Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia line HL-60. Blood, 1991;78:339-344
51. Kasaian M. T., Donaldson D. D., Tchistiakova L., Marquette K., Tan X. Y., Ahmed A., Jacobson B. A., Widom A., Cook T. A., Xu X., Barry A. B., Goldman S. J., Abraham W. M.: Efficacy of IL-13 neutralization in a sheep model of experimental asthma. Am. J. Respir. Cell Mol. Biol., 2007;36:368-376 (Pubitemid 46365288)
52. Kasaian M. T., Miller K. D.: IL-13 as a therapeutic target for respiratory disease. Biochem. Pharmacol., 2008;76:147-155
53. Kasaian M. T., Tan X. Y., Jin M., Fitz L., Marquette K., Wood N., Cook T. A., Lee J., Widom A., Agostinelli R., Bree A., Schlerman F. J., Olland S., Wadanoli M., Sypek J., Gill D., Goldman S. J., Tchistiakova L.: Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys. J. Pharmacol. Exp. Ther., 2008;325:882-892 (Pubitemid 351724334)
54. Kay A. B., Menzies-Gow A.: Eosinophils and interleukin-5: the debate continues. Am. J. Respir. Crit. Care Med., 2003;167:1586-1587 (Pubitemid 36760670)
55. Kips J. C., O'Connor B. J., Inman M. D., Svensson K., Pauwels R. A., O'Byrne P. M.: A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am. J. Respir. Crit. Care Med., 2000;161:996-1001 (Pubitemid 30171763)
56. Kips J. C., O'Connor B. J., Langley S. J., Woodcock A., Kerstjens H. A., Postma D. S., Danzig M., Cuss F., Pauwels R. A.: Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am. J. Respir. Crit. Care Med., 2003;167:1655-1659 (Pubitemid 36760679)
57. Kotsimbos A. T., Hamid Q.: IL-5 and IL-5 receptor in asthma. Mem. Inst. Oswaldo Cruz, 1997;92(Suppl. 2):75-91
58. Krause S., Behrends J., Borowski A., Lohrmann J., Lang S., Myrtek D., Lorenzen T., Virchow J. C., Luttmann W., Friedrich K.: Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha 1. Mol. Immunol., 2006;43:1799-1807
59. Kuperman D. A., Huang X., Koth L. L., Chang G. H., Dolganov G. M., Zhu Z., Elias J. A., Sheppard D., Erle D. J.: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med., 2002;8:885-889
60. Kuperman D., Schofield B., Wills-Karp M., Grusby M. J.: Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med., 1998;187:939-948 (Pubitemid 28141667)
61. Laporte J. C., Moore P. E., Baraldo S., Jouvin M. H., Church T. L., Schwartzman I. N., Panettieri R. A. Jr., Kinet J. P., Shore S. A.: Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med., 2001;164:141-148 (Pubitemid 33151311)
62. Leckie M. J., tenBrinke A., Khan J., Diamant Z., O'Connor B. J., Walls C. M., Mathur A. K., Cowley H. C., Chung K. F., Djukanovic R., Hansel T. T., Holgate S. T., Sterk P. J., Barnes P. J.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet, 2000;356:2144-2148
63. Lentsch A. B., Shanley T. P., Sarma V., Ward P. A.: In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J. Clin. Invest., 1997;100:2443-2448 (Pubitemid 27514883)
64. Leonard W. J., Lin J. X.: Cytokine receptor signaling pathways. J. Allergy Clin. Immunol., 2000;105:877-888 (Pubitemid 30324393)
65. Liu L. Y., Sedgwick J. B., Bates M. E., Vrtis R. F., Gern J. E., Kita H., Jarjour N. N., Busse W. W., Kelly E. A.: Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J. Immunol., 2002;169:6459-6466 (Pubitemid 36903496)
66. Lively T. N., Kossen K., Balhorn A., Koya T., Zinnen S., Takeda K., Lucas J. J., Polisky B., Richards I. M., Gelfand E. W.: Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. J. Allergy Clin. Immunol., 2008;121:88-94
67. Lopez A. F., Vadas M. A., Woodcock J. M., Milton S. E., Lewis A., Elliott M. J., Gillis D., Ireland R., Olwell E., Park L. S.: Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J. Biol. Chem., 1991;266:24741-24747 (Pubitemid 21909004)
68. Luttmann W., Knoechel B., Foerster M., Matthys H., Virchow J. C. Jr., Kroegel C.: Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol., 1996;157:1678-1683 (Pubitemid 126449110)
69. Malavia N. K., Mih J. D., Raub C. B., Dinh B. T., George S. C.: IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir. Res., 2008;9:27
70. Marsh D. G., Neely J. D., Breazeale D. R., Ghosh B., Freidhoff L. R., Ehrlich-Kautzky E., Schou C., Krishnaswamy G., Beaty T. H.: Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science, 1994;264:1152-1156 (Pubitemid 24210678)
71. Mauser P. J., Pitman A. M., Fernandez X., Foran S. K., Adams G. K. III., Kreutner W., Egan R. W., Chapman R. W.: Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med., 1995;152:467-472
72. McKenzie A. N., Ely B., Sanderson C. J.: Mutated interleukin-5 monomers are biologically inactive. Mol. Immunol., 1991;28:155-158
73. Mentink-Kane M. M., Cheever A. W., Thompson R. W., Hari D. M., Kabatereine N. B., Vennervald B. J., Ouma J. H., Mwatha J. K., Jones F. M., Donaldson D. D., Grusby M. J., Dunne D. W., Wynn T. A.: IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. USA, 2004;101:586-590 (Pubitemid 38084680)
74. Meyers D. A., Postma D. S., Panhuysen C. I., Xu J., Amelung P. J., Levitt R. C., Bleecker E. R.: Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics, 1994;23:464-470 (Pubitemid 24308269)
75. Migita M., Yamaguchi N., Mita S., Higuchi S., Hitoshi Y., Yoshida Y., Tomonaga M., Matsuda I., Tominaga A., Takatsu K.: Characterization of the human IL-5 receptors on eosinophils. Cell. Immunol., 1991;133:484-497
76. Minamitake Y., Kodama S., Katayama T., Adachi H., Tanaka S., Tsujimoto M.: Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells. J. Biochem., 1990;107:292-297 (Pubitemid 20063828)
77. Minshall E. M., Leung D. Y., Martin R. J., Song Y. L., Cameron L., Ernst P., Hamid Q.: Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol., 1997, 17:326-333 (Pubitemid 127500837)
78. Minty A., Chalon P., Derocq J. M., Dumont X., Guillemot J. C., Kaghad M., Labit C., Leplatois P., Liauzun B., Miloux B., Minty C., Casellas P., Loison G., Lupker J., Shire D., Ferrara P., Caput D.: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature, 1993;362:248-250 (Pubitemid 23093630)
79. Morokata T., Ida K., Yamada T.: Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int. Immunopharmacol., 2002;2:1693-1702 (Pubitemid 35284607)
80. Moynihan B. J., Tolloczko B., El Bassam S., Ferraro P., Michoud M. C., Martin J. G., Laberge S.: IFN-γ, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13. Respir. Res., 2008;9:84
81. Nair P., Pizzichini M. M., Kjarsgaard M., Inman M. D., Efthimiadis A., Pizzichini E., Hargreave F. E., O'Byrne P. M.: Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med., 2009;360:985-993
82. Nicola N. A., Metcalf D.: Subunit promiscuity among hemopoietic growth factor receptors. Cell, 1991;67:1-4 (Pubitemid 121001419)
83. Noah T. L., Tudor G. E., Ivins S. S., Murphy P. C., Peden D. B., Henderson F. W.: Repeated measurement of nasal lavage fluid chemokines in school-age children with asthma. Ann. Allergy Asthma Immunol., 2006;96:304-310 (Pubitemid 43277169)
84. Ochiai K., Omura M., Mochizuki A., Ito M., Tomioka H.: Human umbilical vein endothelial cells support interleukin-3-and interleukin-5-induced eosinophil differentiation from cord blood CD34+ cells. Int. Arch. Allergy Immunol., 1999;120(Suppl. 1):2-6 (Pubitemid 29457351)
85. Oettgen H. C., Geha R. S.: IgE regulation and roles in asthma pathogenesis. J. Allergy Clin. Immunol., 2001;107:429-440 (Pubitemid 32210021)
86. Ogata H., Ford D., Kouttab N., King T. C., Vita N., Minty A., Stoeckler J., Morgan D., Girasole C., Morgan J. W., Maizel A. L.: Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J. Biol. Chem., 1998;273:9864-9871 (Pubitemid 28183083)
87. Park L. S., Friend D., Sassenfeld H. M., Urdal D. L.: Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med., 1987;166:476-488 (Pubitemid 17134026)
88. Pope S. M., Brandt E. B., Mishra A., Hogan S. P., Zimmermann N., Matthaei K. I., Foster P. S., Rothenberg M. E.: IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. J. Allergy Clin. Immunol., 2001;108:594-601 (Pubitemid 32978032)
89. Postma D. S., Bleecker E. R., Amelung P. J., Holroyd K. J., Xu J., Panhuysen C. I., Meyers D. A., Levitt R. C.: Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med., 1995;333:894-900
90. Prieto J., Lensmar C., Roquet A., van der Ploeg I., Gigliotti D., Eklund A., Grunewald J.: Increased interleukin-13 mRNA expression inbronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir. Med., 2000;94:806-814 (Pubitemid 30628243)
91. Proudfoot A. E., Davies J. G., Turcatti G., Wingfield P. T.: Human interleukin-5 expressed in Escherichia coli: assignment of the disulfide bridges of the purified unglycosylated protein. FEBS Lett., 1991;283:61-64
92. Rahaman S. O., Sharma P., Harbor P. C., Aman M. J., Vogelbaum M. A., Haque S. J.: IL-13Ra2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res., 2002;62:1103-1109 (Pubitemid 34160294)
93. Ramos-Barbon D., Ludwig M. S., Martin J. G.: Airway remodeling: lessons from animal models. Clin. Rev. Allergy Immunol., 2004;27:3-21 (Pubitemid 39274066)
94. Robinson D., Hamid Q., Bentley A., Ying S., Kay A. B., Durham S. R.: Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol., 1993;92:313-324 (Pubitemid 23254120)
95. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B.: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med., 1992;326:298-304
96. Saha S. K., Berry M. A., Parker D., Siddiqui S., Morgan A., May R., Monk P., Bradding P., Wardlaw A. J., Pavord I. D., Brightling C. E.: Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J. Allergy Clin. Immunol., 2008;121:685-691 (Pubitemid 351323866)
97. Sanderson C. J.: Interleukin-5, eosinophils, and disease. Blood, 1992;79:3101-3109
98. Sehmi R., Wardlaw A. J., Cromwell O., Kurihara K., Waltmann P., Kay A. B.: Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood, 1992;79:2952-2959
99. Shardonofsky F. R., Venzor J. 3rd., Barrios R., Leong K. P., Huston D. P.: Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J. Allergy Clin. Immunol., 1999;104:215-221 (Pubitemid 29364507)
100. Smirnov D. V., Smirnova M. G., Korobko V. G., Frolova E. I.: Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene, 1995;155:277-281
101. Sozzani P., Cambon C., Vita N., Séguélas M. H., Caput D., Ferrara P., Pipy B.: Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol. Chem., 1995;270:5084-5088
102. Tanaka H., Komai M., Nagao K., Ishizaki M., Kajiwara D., Takatsu K., Delespesse G., Nagai H.: Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am. J. Respir. Cell Mol. Biol., 2004;31:62-68 (Pubitemid 38888040)
103. Tavernier J., Devos R., Cornelis S., Tuypens T., Van der Heyden J., Fiers W., Plaetinck G.: A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell, 1991;66:1175-1184 (Pubitemid 121001407)
104. Tavernier J., Van der Heyden J., Verhee A., Brusselle G., Van Ostade X., Vandekerckhove J., North J., Rankin S. M., Kay A. B., Robinson D. S.: Interleukin 5 regulates the isoform expression of its own receptor a-subunit. Blood, 2000;95:1600-1607 (Pubitemid 30120819)
105. Tliba O., Deshpande D., Chen H., Van Besien C., Kannan M., Panettieri R. A. Jr., Amrani Y.: IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br. J. Pharmacol., 2003;140:1159-1162 (Pubitemid 38117418)
106. Tominaga A., Takahashi T., Kikuchi Y., Mita S., Naomi S., Harada N., Yamaguchi N., Takatsu K.: Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5. J. Immunol., 1990;144:1345-1352 (Pubitemid 20072905)
107. Tominaga A., Takaki S., Koyama N., Katoh S., Matsumoto R., Migita M., Hitoshi Y., Hosoya Y., Yamauchi S., Kanai Y., Miyazaki J. I., Usuku G., Yamamura K. I., Taktsu K.: Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med., 1991;173:429-437
108. Tomkinson A., Kanehiro A., Rabinovitch N., Joetham A., Cieslewicz G., Gelfand E. W.: The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med., 1999;160:1283-1291 (Pubitemid 29487472)
109. de Vries J. E.: Molecular and biological characteristics of interleukin-13. Chem. Immunol., 1996;63:204-218 (Pubitemid 26091851)
110. de Vries J. E.: The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin. Immunol., 1998;102:165-169 (Pubitemid 28406898)
111. Walter D. M., McIntire J. J., Berry G., McKenzie A. N., Donaldson D. D., DeKruyff R. H., Umetsu D. T.: Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol., 2001;167:4668-4675 (Pubitemid 32954348)
112. Wardlaw A. J., Brightling C. E., Green R., Woltmann G., Bradding P., Pavord I. D.: New insights into the relationship between airway inflammation and asthma. Clin. Sci., 2002;103:201-211
113. Webb D. C., McKenzie A. N., Koskinen A. M., Yang M., Mattes J., Foster P. S.: Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol., 2000;165:108-113 (Pubitemid 30429497)
114. Wen F. Q., Kohyama T., Liu X., Zhu Y. K., Wang H., Kim H. J., Kobayashi T., Abe S., Spurzem J. R., Rennard S. I.: Interleukin-4-and interleukin-13- enhanced transforming growth factor-β2 production in cultured human bronchial epithelial cells is attenuated by interferongamma. Am. J. Respir. Cell Mol. Biol., 2002;26:484-490 (Pubitemid 34253933)
115. Wenzel S. E., Schwartz L. B., Langmack E. L., Halliday J. L., Trudeau J. B., Gibbs R. L., Chu H. W.: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med., 1999;160:1001-1008 (Pubitemid 29442043)
116. Wenzel S., Wilbraham D., Fuller R., Getz E. B., Longphre M.: Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet, 2007;370:1422-1431 (Pubitemid 47576168)
117. Wills-Karp M.: Interleukin-13 in asthma pathogenesis. Immunol. Rev., 2004;202:175-190 (Pubitemid 39576912)
118. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T. Y., Karp C. L., Donaldson D. D.: Interleukin-13: central mediator of allergic asthma. Science, 1998;282:2258-2261 (Pubitemid 29004074)
119. Wynn T. A.: IL-13 effector functions. Annu. Rev. Immunol., 2003;21:425-456 (Pubitemid 37174537)
120. Yamagata T., Ichinose M.: Agents against cytokine synthesis or receptors. Eur. J. Pharmacol., 2006;533:289-301 (Pubitemid 43340020)
121. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K.: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med., 1988;167:1737-1742
122. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K.: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med., 1988;167:43-56 (Pubitemid 18093692)
123. Yang G., Volk A., Petley T., Emmell E., Giles-Komar J., Shang X., Li J., Das A. M., Shealy D., Griswold D. E., Li L.: Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine, 2004;28:224-232 (Pubitemid 39573497)
124. Zheng T., Liu W., Oh S. Y., Zhu Z., Hu B., Homer R. J., Cohn L., Grusby M. J., Elias J. A.: IL-13 receptor a2 selectively inhibits IL-13-induced responses in the murine lung. J. Immunol., 2008;180:522-529
125. Zhu Z., Homer R. J., Wang Z., Chen Q., Geba G. P., Wang J., Zhang Y., Elias J. A.: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest., 1999;103:779-788 (Pubitemid 29152623)
126. Zurawski G., de Vries J. E.: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today, 1994;15:19-26